Stocks
CONMED (CNMD) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 179.3 | 7.80 | 192.5 | 272.2 | 154.5 | 211.4 | ||
| Changes by years, y/y, % | +52% | -96% | +2 368% | +41% | -43% | +5.5% | |||
CONMED. EBITDA US GAAP, bln rub
CONMED. EBITDA US GAAP, changes, %
CONMED. EBITDA US GAAP, sum by quarters, bln rub
CONMED (CNMD) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 24.4 | 50.9 | 25.0 | 55.5 | 38.3 | 211.4 | |
| Changes by years, y/y, % | -54% | -22% | -70% | -21% | +57% | |||
| Changes by quarters, q/q, % | -65% | +109% | -51% | +122% | -31% | |||
